POTELIGEO 4 mg/mL concentrate for solution for infusion
0761-016
Phase 2 small_molecule active
Quick answer
POTELIGEO 4 mg/mL concentrate for solution for infusion for Mycosis fungoides/Sezary syndrome recurrent is a Phase 2 program (small_molecule) at KYOWA KIRIN AUSTRALIA PTY LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- KYOWA KIRIN AUSTRALIA PTY LTD
- Indication
- Mycosis fungoides/Sezary syndrome recurrent
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active